This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morino, K. Articles by Kikkawa, R. Search for Related Content PubMed PubMed Citation Articles by Morino, K. Articles by Kikkawa, R.

Insulin-Induced c-Jun N-Terminal Kinase Activation Is Negatively Regulated by Protein Kinase C ¹

Third Department of Medicine, Shiga University of Medical Science, Seta, Otsu, Shiga 520-2192, Japan

Address all correspondence and requests for reprints to: Hiroshi Maegawa, Third Department of Medicine, Shiga University of Medical Science, Seta, Otsu, Shiga, 520-2192, Japan. E-mail: maegawa{at}belle.shiga-med.ac jp.

We investigated the role of protein kinase C (PKC) in insulin-induced c-Jun N-terminal kinase (JNK) activation in rat 1 fibroblasts expressing human insulin receptors. Insulin treatment led to increased SAPK/ERK kinase 1 (SEK1) phosphorylation, and then stimulated JNK activity in a dose- and time-dependent manner, as measured either by a solid-phase kinase assay using glutathione S-transferase (GST)-c-Jun fusion protein as a substrate, or by quantitation of the levels of phosphorylated JNK by Western blotting using anti-phospho-JNK antibody. Insulin-induced JNK activation was potentiated by either preincubating cells with 2 nM GF109203X (PKC inhibitor) or down-regulation of PKC by overnight treatment with 100 nM tetradecanoyl phorbol acetate. In contrast, brief preincubation with 100 nM tetradecanoyl phorbol acetate inhibited the insulin- induced JNK activation. Furthermore, we found that 5 µM rottlerin, a PKC inhibitor, enhanced insulin-induced JNK activation, but a PKCß inhibitor, LY333531, had no effect. Consistent with these findings, overexpression of PKC led to decreased insulin-induced JNK activation, whereas overexpression of PKCß had no effect. Although overexpression of wild-type PKC attenuated insulin-induced JNK activation, a kinase-dead PKC mutant did not cause such attenuation. Finally, we found that the magnitude of insulin-induced JNK activation was inversely correlated with the expression level of PKC among different cell lines. In conclusion, the expression of PKC may negatively regulate insulin-induced JNK activation.

This article has been cited by other articles:

				S. Shimizu, H. Maegawa, K. Egawa, K. Shi, M. Bryer-Ash, and A. Kashiwagi Mechanism for Differential Effect of Protein-Tyrosine Phosphatase 1B on Akt Versus Mitogen-Activated Protein Kinase in 3T3-L1 Adipocytes Endocrinology, December 1, 2002; 143(12): 4563 - 4569. [Abstract] [Full Text] [PDF]

				K. Egawa, H. Maegawa, K. Shi, T. Nakamura, T. Obata, T. Yoshizaki, K. Morino, S. Shimizu, Y. Nishio, E. Suzuki, et al. Membrane Localization of 3-Phosphoinositide-dependent Protein Kinase-1 Stimulates Activities of Akt and Atypical Protein Kinase C but Does Not Stimulate Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes J. Biol. Chem., October 4, 2002; 277(41): 38863 - 38869. [Abstract] [Full Text] [PDF]